HPCL, Godrej Consumer, Ashok Leyland in focus

Image
Capital Market
Last Updated : May 20 2022 | 9:04 AM IST

HPCL: The company reported consolidated net profit of Rs 2018.45 crore in Q4 FY22 as compared to net profit of Rs 3060.70 crore in Q4 FY21. Total income rose to Rs 106533.84 crore from Rs 85754.76 crore.

Godrej Consumer Products: The company reported consolidated net profit of Rs 363.24 crore in Q4 FY22 as compared to net profit of Rs 365.84 crore in Q4 FY21. Total income rose to Rs 2939.58 crore from Rs 2747.31 crore.

Ashok Leyland: The company reported standalone net profit of Rs 901 crore in Q4 FY22 as compared to net profit of Rs 241 crore in Q4 FY21. Revenue rose to Rs 8744 crore from 7000 crore.

Biocon: Biocon Biologics, a subsidiary of Biocon, and Viatris Inc. announced on Thursday that Abevmy (bBevacizumab) is now available in Canada. Abevmy is a recombinant humanized monoclonal antibody that selectively binds to human vascular endothelial growth factor (VEGF) and neutralizes its biologic activity.

Eros International Media: The company's board approved Rs 405 crore by issuing 13.50 crore convertible warrants at Rs 30 a share.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 20 2022 | 8:55 AM IST

Next Story